Dr. Bell is a fellowship-trained head and neck surgeon and is currently Physician Executive Director of the Division of Surgical Oncology, Radiation Oncology, and Clinical Programs for Providence Cancer Institute- Oregon; Medical Director of the Providence Head and Neck Cancer Program; and Member and Director of Surgical Oncology Research at the Earle A. Chiles Research Institute, a division of the Providence Cancer Institute. In these roles he provides vision, leadership, strategy and oversight for all clinical oncology programs and surgical oncology research throughout the eight-hospital Oregon region. In addition, Dr. Bell maintains an active clinical practice focused entirely on the comprehensive surgical management of patients with head and neck cancer. Currently, his research focuses on modulating the tumor microenvironment prior to surgery by reversing immunosuppression through monoclonal antibodies, vaccines and bioengineered materials for local drug delivery.
Using his surgical practice to run clinical trials in the neoadjuvant setting, Dr. Bell’s work bridges basic, translational and clinical activities. He has also contributed to the clinical development of virtual surgical planning, transoral robotic surgery, and sentinel lymph node biopsy for patients with head and neck cancer. His work has been published in more than 150 scientific articles and book chapters and he is co-author of two major textbooks published by Elsevier, including "Oral, Head and Neck Oncology and Reconstructive Surgery".
Through his appointment as Co-Chair of the Cancer Leadership Council at Providence, he also provides leadership for the entire cancer service line in its 52-hospital health system spanning 7 western U.S. states, within which more than 45,000 cancer patients are treated annually.
Dr. Dyalram is currently an Assistant Professor and Associate Program Director in the Department of Oral and Maxillofacial Surgery at the University of Maryland Medical Center. She attended New York University College of Arts and Science for her undergraduate degree. She then obtained her Dental Degree from New York University College of Dentistry and her Medical Degree from SUNY Downstate Medical Center. At the completion of Oral Maxillofacial Surgical Residency training at SUNY Downstate Medical Center/ Kings County Hospital Center in NYC, she left her home town, to pursue fellowship training in Head and Neck Oncology and Microvascular Reconstruction at the University of Maryland Medical Center with Dr. Robert Ord and Dr. Joshua Lubek. Here she received training and mentorship in surgical excellence that was second to none. Following these two years of fellowship training she accepted an academic positing at the University of Maryland Medical Center, Department of Oral Maxillofacial Surgery.
Since this time she has remained at the University of Maryland and she is presently the Associate Program director of the OMFS residency training program. The outstanding oral Maxillofacial Surgical Residency program at the University of Maryland trains 16 individuals. She is one of the core faculty in the Head and Neck Oncology / Microvascular Reconstruction fellowship training program. Here she trains two fellows in ablative techniques and microvascular reconstruction. She is also course director and faculty advisor to students at the University of Maryland Dental School.
Dr. Dyalram had been the awarded the prestigious Faculty Educator Development Award by the Oral Maxillofacial Surgery Foundation. This echoes her commitment as an educator to student, resident and fellows. Dr. Dyalram is a board certified by the American Board of Oral & Maxillofacial Surgery. She is a member of the Face Transplant Team at the University of Maryland Medical Center.
Dr. Dyalram maintains a clinical interest in tumors of the jaw, benign and malignant; squamous cell carcinoma of the head and neck, salivary gland tumors, osteoradionecrosis and medication related osteonecrosis of the jaw, head and neck reconstruction, robotic surgery and trigeminal nerve repair.
Dr. Fernandes is a Board certified Oral and Maxillofacial Surgeon. He holds dual appointments in Oral and Maxillofacial Surgery and Surgical Oncology at the University of Florida College of Medicine - Jacksonville. Currently, he serves as the Chief of Head and Neck Surgery, Director of the Head and Neck/Microvascular Reconstructive Surgery fellowship and Associate Chairman of the Department of Oral & Maxillofacial Surgery.
He received his undergraduate degree in Biology from Boston University and Doctorate in Dental Medicine from the Goldman School of Dental Medicine, also at Boston University.
He is a graduate of the University of Alabama at Birmingham School of Medicine and completed residency training in Oral & Maxillofacial Surgery at the University of Alabama at Birmingham as well. Upon completion of his residency, he began a 2 year combined Head and Neck Oncology and Microvascular Surgery Fellowship at the University of Maryland College of Medicine. Since completing his fellowship training he has maintained an academic appointment at the University of Florida College of Medicine in Jacksonville.
Dr. Fernandes currently serves as chair of the education committee of the International Association of Oral and Maxillofacial Surgeons. He has lectured extensively both nationally and internationally and has authored several manuscripts in the areas of head and neck oncology and reconstructive surgery as well a single author textbook in reconstructive surgery of the head and neck.
Dr. Markiewicz is Professor and Chair of the Department of Oral and Maxillofacial Surgery at the University of Buffalo, and adjunct Professor in the Departments of Neurosurgery and Surgery at the Jacob’s School of Medicine and Biomedical Science. He is an attending Head and Neck and Reconstructive Surgeon and Roswell Park Cancer Center, and is Co-director of the Cleft and Craniofacial Team, at the Craniofacial Center of Western New York.
Dr. Markiewicz earned his Dental Degree at the University at Buffalo, and Medical Degree at Oregon Health and Science University where he also completed his General Surgery and Oral and Maxillofacial Surgery training. He obtained a Master’s of Public Health from Harvard University with a concentration in Biostatistics and Epidemiology, and completed a Fellowship in Clinical Investigation at The Massachusetts General Hospital, Boston Massachusetts. Dr. Markiewicz completed a fellowship in Pediatric Cleft and Craniomaxillofacial Surgery, at the Arnold Palmer Hospital for Children, in Orlando Florida. To complete his surgical training, he completed a fellowship in Head and Neck Oncologic and Microvascular Reconstructive Surgery in the Division of Head and Neck Surgery, at the University of Florida, College of Medicine, in Jacksonville Florida.
Dr. Markiewicz’s clinical and research interests are dedicated to the management of Cleft and Craniofacial anomalies in Children and Adults, the treatment of Head and Neck Cancer, and the reconstruction of Congenital and Acquired Defects in Children and Adults.
James C. Melville, DDS, FACS, is an Associate Professor in the Department of Oral and Maxillofacial Surgery at the University of Texas Health Science Center at Houston UTHealth and specializes in Oral, Head & Neck Oncology, and Microvascular Reconstructive Surgery. He graduated from the University of Michigan School of Dentistry in Ann Arbor, Michigan, in 2005 and completed a General Practice Residency at the University of California San Francisco in 2006. He completed a residency in oral and maxillofacial surgery in 2012, followed by fellowships in oral, head, and neck oncology and microvascular reconstructive surgery at the University of Miami/Jackson Memorial Hospital. He was appointed to the UTH OMFS internship director in 2017.
Dr. Melville was awarded the Faculty Educator Development Award (FEDA) in 2019 by the American Association of Oral & Maxillofacial Surgeons (AAOMS). An award given to promising young academic surgeons. He was awarded the AAOMS Advocacy Challenge Coin by the AAOMS Board of Trustees and AAOMS Committee on Government Affairs in 2020.
AAOMS designed its own Challenge Coin to recognize oral and maxillofacial surgeons who have made significant advocacy contributions on behalf of the Association. The AAOMS Challenge Coin is awarded to those elite few who transcend the efforts of their colleagues to further the specialty through advocacy. Dr. Melville serves as the Vice-President of the Oral & Maxillofacial Section of the American Association for Dental, Oral, and Craniofacial Research (AADOCR) and will be become the President in 2023. He was also appointed the Vice President of the AAOMS Clinical Interest Group (CIG) in Neurologic Disorders 2021.
Dr. Melville is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American Association of Oral and Maxillofacial Surgeons, the American Academy of Craniomaxillofacial Surgeons, American College of Oral & Maxillofacial Surgeons, and the American College of Surgeons.
He has written a Springer textbook on maxillofacial reconstruction and contributed to 22 chapters in textbooks concerning oral and maxillofacial surgery, oncology, maxillofacial reconstruction, microvascular reconstruction, and tissue engineering. In addition, he is the author of more than 35 articles in peer-reviewed journals. He is a reviewer for the Journal of Oral and Maxillofacial Surgery (JOMS), Triple OOOO Journal, Journal of Cranio-Maxillofacial Surgery, Journal of Tissue Engineering, Bioengineering & Translational Medicine (Wiley), Journal of Biomedical Materials Research, Experimental Dermatology, Japanese Dental Science Review, and of Journal of American Dental Association (JADA).
Dr. Morlandt was born and raised in Floresville, Texas and graduated from Baylor University. He completed his DDS magna cum laude at the University of Texas Health Sciences Center in San Antonio, Texas, and received his MD and internship and residency in Oral and Maxillofacial Surgery from the University of Alabama School of Medicine. Dr. Morlandt then went on to complete a fellowship in head and neck oncology and microsurgery at the University of Florida College of Medicine in Jacksonville, Florida. He returned to Birmingham where he currently serves as Chief of the Section of Oral Oncology within the Department of Oral and Maxillofacial Surgery at UAB Medicine and is a full time academic head and neck surgeon. He is Director of the Head and Neck Oncology Fellowship program at UAB. Dr. Morlandt is a Scientist in the Cancer Chemoprevention Program with the UAB Comprehensive Cancer Center. In 2015, Dr. Morlandt received the AAOMS Faculty Educator Development Award and has been inducted into the American Head and Neck Society and is a Fellow of the American College of Surgeons. He is a Diplomate of the American Board of Oral and Maxillofacial Surgery.
Dr. Morlandt specializes in oral oncology, head and neck microvascular surgery, and oral and maxillofacial surgery. He has authored several peer-reviewed scientific articles and textbook chapters on head and neck ablative and reconstructive surgery. He is particularly interested in helping doctors and their staff identify head and neck cancers and in optimizing patient outcomes following major head and neck surgery.
Andrew Salama, DDS, MD, is the chief of oral and maxillofacial surgery at Long Island Jewish Medical Center at Northwell. He specializes in head and neck cancer and microvascular reconstruction.
University of Maryland Dental School 1999,Dentistry
University of Maryland School of Medicine, 2002, Medicine
Residency: University of Maryland Medical Center, 2005, Oral and Maxillofacial Surgery
Fellowships: University of Maryland Medical Center, 2007, Head and Neck Surgery
Dr. Young received his DDS from the University of Toronto. After graduation, he entered a combined oral & maxillofacial surgery residency/MD/PhD program at the University of Texas Health Science Center at Houston (UTHealth) and the Department of Bioengineering at Rice University. Dr. Young realized there is a real need for innovative new approaches to treating oral squamous cell cancer. He decided to pursue postdoctoral fellowship training at the Harvard University School of Engineering and Applied Sciences and was awarded a National Institutes of Health (NIH) K99/R00 Dentist Scientist Pathway to Independence Award to investigate the use of “immunoengineering” approaches to treat oral cancer.
In 2015, Dr. Young returned to the Department of OMS at UTHealth where his research involves the development and characterization of biomaterials-based platform technologies focused in two areas relevant to oral & maxillofacial surgery: cancer immunotherapy and craniofacial tissue regeneration. The focus of his NIH R21 and R01 grant-funded current research in immuno-oncology is to develop novel material-based immunotherapies for the treatment of head and neck cancer and explore mechanisms of how this approach may synergize with other modalities of treatment, such as chemo/radiation therapy. He is also the department’s Director of Research and helps to provide oversight, mentorship, and project guidance for residents’ projects throughout their training.